Mitral transcatheter edge-to-edge repair as a treatment option for hemolytic anemia after surgical mitral valve repair: A report of three cases

Hemolytic anemia following surgical mitral valve repair is rare, and the role of mitral transcatheter edge-to-edge repair (TEER) in its treatment is unknown. We present three cases of hemolytic anemia following surgical mitral valve repair treated with mitral TEER. All three patients experienced resolution of hemolysis after mitral TEER.